1)Ford B: Pain in Parkinson's disease. Mov Disord 25(Suppl 1): S98-S103, 2010
2)Poewe WH, Lees AJ, Stern GM: Dystonia in Parkinson's disease: clinical and pharmacological features. Ann Neurol 23: 73-78, 1988
3)望月秀樹: Striatal foot. 山本光利(編): パーキンソン病—臨床の諸問題2. 中外医学社, 東京, 2010, pp90-93
4)Tinazzi M, Del Vesco C, Fincati E, Ottaviani S, Smania N, et al: Pain and motor complications in Parkinson's disease. J Neurol Neurosurg Psychiatry 77: 822-825, 2006
5)Freynhagen R, Parada HA, Calderon-Ospina CA, Chen J, Emril DR, et al: Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin 35: 1011-1018, 2019
6)Kasunich A, Kilbane C, Wiggins R: Movement disorders moment: pain & palliative care in movement disorders. Practical Neurology 19: 63-67, 2021
7)Buhmann C, Kassubek J, Jost WH: Management of pain in Parkinson's disease. J Parkinsons Dis 10: S37-S48, 2020
8)Nègre-Pagès L, Regragui W, Bouhassira D, Grandjean H, Rascol O; DoPaMiP Study Group: chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord 23: 1361-1369, 2008
9)Kassubek J, Chaudhuri KR, Zesiewicz T, Surmann E, Boroojerdi B, et al: Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study. BMC Neurol 14: 42, 2014[doi: 10.1186/1471-2377-14-42]
10)Tsuboi Y, Koebis M, Kogo Y, Ishida T, Suzuki I, et al: Effects of safinamide adjunct therapy on pain in patients with Parkinson's disease: post hoc analysis of a Japanese phase 2/3 study. J Neurol Sci 429: 118070, 2021[doi: 10.1016/j.jns.2021.118070]
11)Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, et al: Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 24: 1468-1474, 2009
12)Buongiorno M, Antonelli F, Cámara A, Puente V, de Fabregues-Nebot O, et al: Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: the Barcelona registry. Parkinsonism Relat Disord 21: 871-876, 2015
13)Iwaki H, Ando R, Tada S, Nishikawa N, Tsujii T, et al: A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease. J Neurol Sci 414: 116833, 2020[doi: 10.1016/j.jns.2020.116833]
14)Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, et al: “Off” painful dystonia in Parkinson's disease treated with botulinum toxin. Mov Disord 10: 333-336, 1995
15)Artusi CA, Bortolani S, Merola A, Zibetti M, Busso M, et al: Botulinum toxin for Pisa syndrome: an MRI-, ultrasound- and electromyography-guided pilot study. Parkinsonism Relat Disord 62: 231-235, 2019
16)Bruno V, Freitas ME, Mancini D, Lui JP, Miyasaki J, et al: Botulinum toxin type A for pain in advanced Parkinson's disease. Can J Neurol Sci 45: 23-29, 2018
17)Cury RG, Galhardoni R, Teixeira MJ, Dos Santos Ghilardi MG, Silva V, et al: Subthalamic deep brain stimulation modulates conscious perception of sensory function in Parkinson's disease. Pain 157: 2758-2765, 2016
18)Pellaprat J, Ory-Magne F, Canivet C, Simonetta-Moreau M, Lotterie JA, et al: Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease. Parkinsonism Relat Disord 20: 662-664, 2014
19)Nishioka K, Nakajima M: Beneficial therapeutic effects of spinal cord stimulation in advanced cases of Parkinson's disease with intractable chronic pain: a case series. Neuromodulation 18: 751-753, 2015
20)Fénelon G, Goujon C, Gurruchaga JM, Cesaro P, Jarraya B, et al: Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson's disease. Parkinsonism Relat Disord 18: 213-214, 2012
21)Terkelsen AJ, Bach FW, Jensen TS: Experimental forearm immobilization in humans induces cold and mechanical hyperalgesia. Anesthesiology 109: 297-307, 2008
22)de la Cruz SP: Effectiveness of aquatic therapy for the control of pain and increased functionality in people with Parkinson's disease: a randomized clinical trial. Eur J Phys Rehabil Med 53: 825-832, 2017
23)Kataoka H, Sugie K: Recent advancements in lateral trunk flexion in Parkinson disease. Neurol Clin Pract 9: 74-82, 2019